 SAN CARLOS, Calif., Nov. 10, 2020 GLOBE NEWSWIRE -- BioCardia, Inc. NASDAQ: BCDA, a leader in the development of autologous and allogenic cell therapies, today reported financial results and business highlights for the third quarter of 2020 and filed its quarterly report on Form 10-Q for the three and nine months ended September 30, 2020 with the Securities and Exchange Commission on November 10, 2020. 